Article Details

Celularity and MaxCyte Sign Strategic Platform License to Advance Celularity's Off-the-shelf ...

Retrieved on: 2021-05-25 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Celularity and MaxCyte Sign Strategic Platform License to Advance Celularity's Off-the-shelf .... View article details on hiswai: https://www.prnewswire.com/news-releases/celularity-and-maxcyte-sign-strategic-platform-license-to-advance-celularitys-off-the-shelf-allogeneic-cellular-therapy-product-candidates-301298370.html

Excerpt

("Celularity"), a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up